๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX ยท Real-Time Price ยท USD
9.38
-0.22 (-2.29%)
At close: Nov 18, 2026, 4:00 PM EST
9.24
-0.14 (-1.49%)
Pre-market: Nov 19, 2026, 4:01 AM EST

Bicara Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Income
-237.03-155.6-82.39-39.89-37.66
Net Income
-220.28-137.95-68-51.99-37.85
Earnings Per Share
-3.49-2.52-4.05-89.61-88.20
EPS Growth
-----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
442.35414.8489.71230.444.16
Total Debt
0.881.710.740.66-
Net Cash (Debt)
441.47413.09488.97229.784.16
Net Cash Growth
53.19%-15.52%112.80%5426.29%-
Net Cash Per Share
7.007.5629.10396.109.69

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-161.73-106.83-74.75-45.63-32.08
Capital Expenditures
-1.02-0.28-0.07-0.59-0.19
Free Cash Flow
-162.75-107.11-74.82-46.21-32.27
Free Cash Flow Growth
-----

Valuation

Selected indicators aren't available for this stock.